Title : Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

Pub. Date : 2004 Oct 15

PMID : 15217830






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low-dose combined PK and bortezomib treatment overcomes the growth, survival, and drug resistance conferred by interleukin-6 or insulin growth factor within the MM bone marrow milieu. Bortezomib interleukin 6 Homo sapiens